Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study

Young Min Kim, Suk Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae, Myeong Jun Song, Ji Woong Jang, Soon Young Ko, Jae Dong Lee

Clin Mol Hepatol. 2018;24(3):311-318. Published online June 4, 2018

DOI: https://doi.org/10.3350/cmh.2017.0070

View: 8048 Download: 204 Web of Science: 11 Crossref: 11

Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study

Byeong Wook Cho, Seok Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae

Clin Mol Hepatol. 2017;23(1):51-56. Published online March 16, 2017

DOI: https://doi.org/10.3350/cmh.2016.0053

View: 8239 Download: 213 Web of Science: 12 Crossref: 14

Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience

Sang Seok Lee, Hyun Sung Shin, Hyung Joon Kim, Su Jin Lee, Hyun Suk Lee, Kyung Hee Hyun, Yong Hyun Kim, Byoung Woon Kwon, Jin Hyung Han, Hoon Choi, Bae Hwan Kim, Joon Hyuk Lee, Ha Yan Kang, Hyun Deok Shin, Il Han Song

Clin Mol Hepatol. 2012;18(1):48-55. Published online March 22, 2012

DOI: https://doi.org/10.3350/kjhep.2012.18.1.48

View: 8534 Download: 54 Crossref: 32

Case Report

Ruptured duodenal varices arising from the main portal vein successfully treated with endoscopic injection sclerotherapy: a case report

Ha Yan Kang, Won Kyung Lee, Yong Hyun Kim, Byung Woon Kwon, Myung Soo Kang, Suk Bae Kim, Il Han Song

Clin Mol Hepatol. 2011;17(2):152-156. Published online June 23, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.2.152

View: 6054 Download: 53 Crossref: 11

1 |

Viewed By 4873	MAFLD: How is it different from NAFLD?
Viewed By 4821	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4665	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4401	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4341	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 94	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search